Minggao Shi Selected Research

edoxaban

1/2022	Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.
7/2021	Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.
2/2021	Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial.
11/2020	Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial.
1/2019	Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
1/2019	Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial.
11/2018	Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.
2/2018	Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
8/2016	Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial.
2/2016	Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minggao Shi Research Topics

Disease

19	Hemorrhage 02/2021 - 05/2011
17	Atrial Fibrillation 01/2022 - 10/2010
15	Stroke (Strokes) 01/2022 - 10/2010
8	Embolism (Embolus) 02/2021 - 10/2010
7	Venous Thromboembolism 11/2021 - 09/2010
4	Myocardial Infarction 01/2019 - 10/2010
3	Body Weight (Weight, Body) 02/2021 - 10/2013
2	Pulmonary Embolism 07/2021 - 10/2013
2	Neoplasms (Cancer) 02/2018 - 01/2006
2	Ischemic Stroke 01/2018 - 08/2014
2	Thromboembolism 06/2015 - 10/2010
2	Pain (Aches) 01/2006 - 06/2005
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2021
1	Obesity 11/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2018
1	Heart Failure 01/2016
1	Peripheral Arterial Disease 04/2015
1	Hemorrhagic Stroke 08/2014
1	Transient Ischemic Attack 08/2014
1	Right Ventricular Dysfunction 10/2013
1	Cancer Pain 01/2006

Drug/Important Bio-Agent (IBA)

25	edoxabanIBA 01/2022 - 09/2010
15	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 10/2010
8	AnticoagulantsIBA 11/2021 - 10/2012
8	Factor Xa InhibitorsIBA 11/2018 - 10/2010
6	Factor Xa (Coagulation Factor Xa)IBA 01/2019 - 10/2010
5	Vitamin K FDA Link 11/2018 - 10/2010
3	Pharmaceutical PreparationsIBA 01/2018 - 05/2011
2	CreatinineIBA 01/2022 - 10/2013
2	A-factor (Streptomyces)IBA 01/2016 - 10/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2015 - 08/2013
2	Hydromorphone (Dilaudid)FDA LinkGeneric 01/2006 - 06/2005
1	pro-brain natriuretic peptide (1-76)IBA 11/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2018
1	Dalteparin (Dalteparin Sodium)FDA Link 02/2018
1	Clopidogrel (Plavix)FDA Link 04/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2013
1	Heparin (Liquaemin)FDA LinkGeneric 10/2013
1	Digoxin (Digitek)FDA LinkGeneric 10/2012
1	Biomarkers (Surrogate Marker)IBA 05/2012
1	TabletsIBA 01/2006
1	Opioid Analgesics (Opioids)IBA 01/2006
1	Morphine (MS Contin)FDA LinkGeneric 01/2006

Therapy/Procedure

6	Therapeutics 11/2021 - 10/2013
3	Drug Tapering 01/2022 - 05/2012
1	Transcatheter Aortic Valve Replacement 11/2018
1	Duration of Therapy 02/2018
1	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2010